We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Antimicrobial Therapy Biomarker Enumerates Eosinophil Count Changes

By LabMedica International staff writers
Posted on 01 Aug 2017
Print article
Image: The Coulter LH 780 hematology analyzer (Photo courtesy of Beckman Coulter).
Image: The Coulter LH 780 hematology analyzer (Photo courtesy of Beckman Coulter).
Eosinopenia as a criterion of sepsis has been the subject of debate for decades and the pathophysiology of eosinopenia is related to the migration of eosinophils to the inflammatory site, presumably as a result of chemotactic substances secreted during the acute phase of inflammation.

As a biomarker, eosinopenia has the advantage of not requiring further investigations, because it can be obtained easily from a simple complete blood count (CBC). It has been hypothesized that recovery from eosinopenia during the treatment of bacterial infection may be a marker to evaluate whether a patient is receiving the appropriate antibiotic regimen.

Infectious disease specialists at the Raymond Poincaré Teaching Hospital (Garches, France) conducted a prospective study from February to August 2016. Hospitalized adults suffering from a bacterial infection with eosinopenia, defined as an eosinophil count less than 100/mm3, were included. Patients were divided into two groups according to the first day of effective antimicrobial therapy. They were observed for five days in order to evaluate whether recovery from eosinopenia was predictive of an appropriate antibiotic regimen. The eosinophil count was obtained from the CBC, acquired using a Coulter LH780 hematology analyzer.

The team screened 122 patients and 96 were included. In Group 1, 70 patients received effective antimicrobial therapy from day 0. Their eosinophil count increased significantly between day 0 and day 1. In the second group, 26 patients received delayed effective antimicrobial therapy, and there was no significant difference in eosinophil count between day 0 and day 1. Moreover, eosinophil counts normalized on day five in both groups. The mean duration of antimicrobial therapy was comparable in the two groups (7.7 ± 1.16 days). The antibiotics most often prescribed in both groups were intravenous cephalosporins. During follow-up, all patients were considered cured after day 30.

The authors concluded that the eosinophil count appears to normalize faster than C-reactive protein (CRP) and polymorphonuclear neutrophils in eosinopenic patients on appropriate antimicrobial therapy. This simple test is easy to perform as part of a regular complete blood count, with no additional costs as required for CRP or procalcitonin. The study was published in the August 2017 issue of the International Journal of Infectious Diseases.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.